Pharmacologic and toxicologic properties of a new topically active anti-inflammatory steroid.
D000284:Administration, Oral; D000287:Administration, Topical; D000315:Adrenalectomy; D000621:Aminoisobutyric Acids / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D004487:Edema / Q000188:drug therapy; D005260:Female; D006099:Granuloma / Q000188:drug therapy; D007279:Injections, Subcutaneous; D007928:Lethal Dose 50; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D011188:Potassium / Q000652:urine; D051381:Rats; D012964:Sodium / Q000652:urine; D013950:Thymus Gland / Q000187:drug effects; D014221:Triamcinolone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity
D000621:Aminoisobutyric Acids; D000893:Anti-Inflammatory Agents; D008112:Liver Glycogen; D014221:Triamcinolone; D012964:Sodium; D011188:Potassium